latest news

Imanova Secures License from Cerveau Technologies, Inc. to Manufacture Investigational Tau Ligand, [18F]MK-6240

This week Imanova has signed an agreement that grants the company the right to manufacture for distr...
read full article

MIND MAPS - scanning completed on the first participants

mindmaps ligandsImanova is pleased to announce that the scanning has been completed on the first participants in the...
read full article

Imanova implements three PET ligands for neurodegeneration

MIND MAPS ligands smallIn the scope of the MIND MAPS programme Imanova has recently completed the implementation of three P...
read full article

PET imaging agents may allow earlier diagnosis of cardiotoxicity

Cardiotoxity is one of the most important adverse reactions of chemotherapy, significantly reducing ...
read full article

Imanova receives £1m award from the MRC to develop early markers of dementia - the MIND-MAPS study

Following a £0.5m Medical Research Council (MRC) grant to implement new Positron Emission Tomography...
read full article